Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.
Sharma S, Kotamraju VR, Mölder T, Tobi A, Teesalu T, Ruoslahti E. Sharma S, et al. Among authors: teesalu t. Nano Lett. 2017 Mar 8;17(3):1356-1364. doi: 10.1021/acs.nanolett.6b03815. Epub 2017 Feb 17. Nano Lett. 2017. PMID: 28178415 Free PMC article.
Hyaluronan-binding peptide for targeting peritoneal carcinomatosis.
Ikemoto H, Lingasamy P, Anton Willmore AM, Hunt H, Kurm K, Tammik O, Scodeller P, Simón-Gracia L, Kotamraju VR, Lowy AM, Sugahara KN, Teesalu T. Ikemoto H, et al. Among authors: teesalu t. Tumour Biol. 2017 May;39(5):1010428317701628. doi: 10.1177/1010428317701628. Tumour Biol. 2017. PMID: 28468593 Free PMC article.
Ratiometric in vivo auditioning of targeted silver nanoparticles.
Toome K, Willmore AA, Paiste P, Tobi A, Sugahara KN, Kirsimäe K, Ruoslahti E, Braun GB, Teesalu T. Toome K, et al. Among authors: teesalu t. Nanoscale. 2017 Jul 20;9(28):10094-10100. doi: 10.1039/c7nr04056c. Nanoscale. 2017. PMID: 28695222 Free PMC article.
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.
Scodeller P, Simón-Gracia L, Kopanchuk S, Tobi A, Kilk K, Säälik P, Kurm K, Squadrito ML, Kotamraju VR, Rinken A, De Palma M, Ruoslahti E, Teesalu T. Scodeller P, et al. Among authors: teesalu t. Sci Rep. 2017 Nov 7;7(1):14655. doi: 10.1038/s41598-017-14709-x. Sci Rep. 2017. PMID: 29116108 Free PMC article.
Peptide-guided nanoparticles for glioblastoma targeting.
Säälik P, Lingasamy P, Toome K, Mastandrea I, Rousso-Noori L, Tobi A, Simón-Gracia L, Hunt H, Paiste P, Kotamraju VR, Bergers G, Asser T, Rätsep T, Ruoslahti E, Bjerkvig R, Friedmann-Morvinski D, Teesalu T. Säälik P, et al. Among authors: teesalu t. J Control Release. 2019 Aug 28;308:109-118. doi: 10.1016/j.jconrel.2019.06.018. Epub 2019 Jun 27. J Control Release. 2019. PMID: 31255690
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery.
Lingasamy P, Tobi A, Haugas M, Hunt H, Paiste P, Asser T, Rätsep T, Kotamraju VR, Bjerkvig R, Teesalu T. Lingasamy P, et al. Among authors: teesalu t. Biomaterials. 2019 Oct;219:119373. doi: 10.1016/j.biomaterials.2019.119373. Epub 2019 Jul 19. Biomaterials. 2019. PMID: 31374479 Free article.
Tumor-penetrating peptide for systemic targeting of Tenascin-C.
Lingasamy P, Tobi A, Kurm K, Kopanchuk S, Sudakov A, Salumäe M, Rätsep T, Asser T, Bjerkvig R, Teesalu T. Lingasamy P, et al. Among authors: teesalu t. Sci Rep. 2020 Apr 2;10(1):5809. doi: 10.1038/s41598-020-62760-y. Sci Rep. 2020. PMID: 32242067 Free PMC article.
98 results